O'Brien et al.[9] performed purification of CD133-positive cells in colon carcinoma by flow cytometry and transplanted them into mice, leading to the formation of tumours in renal subcapsule, suggesting that CD133 may be a cancer stem cell marker for colon carcinoma. The gene discussed is PROM1; the disease is colon carcinoma.